BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 33040279)

  • 1. Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in Mice.
    Zarzecki MS; Cattelan Souza L; Giacomeli R; Silva MRP; Prigol M; Boeira SP; Jesse CR
    Neurochem Res; 2020 Dec; 45(12):2959-2977. PubMed ID: 33040279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression.
    Sundaram G; Lim CK; Brew BJ; Guillemin GJ
    J Neuroinflammation; 2020 Jun; 17(1):176. PubMed ID: 32505212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin ameliorates disease severity in a mouse model of multiple sclerosis by modulating the kynurenine pathway.
    Jand Y; Ghahremani MH; Ghanbari A; Ejtemaei-Mehr S; Guillemin GJ; Ghazi-Khansari M
    Sci Rep; 2022 Sep; 12(1):15963. PubMed ID: 36153399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation.
    Garrison AM; Parrott JM; Tuñon A; Delgado J; Redus L; O'Connor JC
    Psychoneuroendocrinology; 2018 Aug; 94():1-10. PubMed ID: 29734055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the kynurenine pathway in human glioma pathophysiology.
    Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
    PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.
    Song P; Ramprasath T; Wang H; Zou MH
    Cell Mol Life Sci; 2017 Aug; 74(16):2899-2916. PubMed ID: 28314892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives.
    Ciapała K; Mika J; Rojewska E
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis.
    Lemos H; Mohamed E; Ou R; McCardle C; Zheng X; McGuire K; Homer NZM; Mole DJ; Huang L; Mellor AL
    Front Immunol; 2020; 11():1256. PubMed ID: 32625215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDO expression in the brain: a double-edged sword.
    Kwidzinski E; Bechmann I
    J Mol Med (Berl); 2007 Dec; 85(12):1351-9. PubMed ID: 17594069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia.
    Réus GZ; Becker IRT; Scaini G; Petronilho F; Oses JP; Kaddurah-Daouk R; Ceretta LB; Zugno AI; Dal-Pizzol F; Quevedo J; Barichello T
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():55-63. PubMed ID: 29030243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis.
    Sakurai K; Zou JP; Tschetter JR; Ward JM; Shearer GM
    J Neuroimmunol; 2002 Aug; 129(1-2):186-96. PubMed ID: 12161035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.
    Duan RN; Yang CL; Du T; Liu A; Wang AR; Sun WJ; Li X; Li JX; Yan CZ; Liu QJ
    J Neuroinflammation; 2021 Jun; 18(1):145. PubMed ID: 34183017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the kynurenine metabolism pathway by Xiaoyao San and the underlying effect in the hippocampus of the depressed rat.
    Wang J; Li X; He S; Hu L; Guo J; Huang X; Hu J; Qi Y; Chen B; Shang D; Wen Y
    J Ethnopharmacol; 2018 Mar; 214():13-21. PubMed ID: 29217494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kynurenine pathway and inflammation in amyotrophic lateral sclerosis.
    Chen Y; Stankovic R; Cullen KM; Meininger V; Garner B; Coggan S; Grant R; Brew BJ; Guillemin GJ
    Neurotox Res; 2010 Aug; 18(2):132-42. PubMed ID: 19921535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.
    Saito K; Nowak TS; Markey SP; Heyes MP
    J Neurochem; 1993 Jan; 60(1):180-92. PubMed ID: 8417138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice.
    Larkin PB; Sathyasaikumar KV; Notarangelo FM; Funakoshi H; Nakamura T; Schwarcz R; Muchowski PJ
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2345-2354. PubMed ID: 27392942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the immune-inflammatory and the kynurenine pathways in rats resistant to antidepressant treatment in model of depression.
    Duda W; Curzytek K; Kubera M; Connor TJ; Fagan EM; Basta-Kaim A; Trojan E; Papp M; Gruca P; Budziszewska B; Leśkiewicz M; Maes M; Lasoń W
    Int Immunopharmacol; 2019 Aug; 73():527-538. PubMed ID: 31176083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of indoleamine 2,3-dioxygenase 1 expression in neurons of the central nervous system through inhibition of histone deacetylases blocks the progression of experimental autoimmune encephalomyelitis.
    Kim CE; Lee SM; Yoon EH; Won HJ; Jung YJ; Jegal Y; Kim DH; Kwon B; Seo SK
    Int Immunopharmacol; 2024 Jun; 134():112246. PubMed ID: 38759372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.
    Notarangelo FM; Wilson EH; Horning KJ; Thomas MA; Harris TH; Fang Q; Hunter CA; Schwarcz R
    Schizophr Res; 2014 Jan; 152(1):261-7. PubMed ID: 24345671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.